NO843587L - Behandling av sykdommer foraarsaket av herpesvira - Google Patents

Behandling av sykdommer foraarsaket av herpesvira

Info

Publication number
NO843587L
NO843587L NO843587A NO843587A NO843587L NO 843587 L NO843587 L NO 843587L NO 843587 A NO843587 A NO 843587A NO 843587 A NO843587 A NO 843587A NO 843587 L NO843587 L NO 843587L
Authority
NO
Norway
Prior art keywords
tea
virus
cultures
drug
hsv
Prior art date
Application number
NO843587A
Other languages
English (en)
Norwegian (no)
Inventor
Joseph A Baldone
Original Assignee
Joseph A Baldone
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joseph A Baldone filed Critical Joseph A Baldone
Publication of NO843587L publication Critical patent/NO843587L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO843587A 1983-01-10 1984-09-10 Behandling av sykdommer foraarsaket av herpesvira NO843587L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45673283A 1983-01-10 1983-01-10

Publications (1)

Publication Number Publication Date
NO843587L true NO843587L (no) 1984-09-10

Family

ID=23813921

Family Applications (1)

Application Number Title Priority Date Filing Date
NO843587A NO843587L (no) 1983-01-10 1984-09-10 Behandling av sykdommer foraarsaket av herpesvira

Country Status (8)

Country Link
EP (1) EP0131050B1 (it)
JP (1) JPH07106980B2 (it)
AU (1) AU569279B2 (it)
CA (1) CA1228551A (it)
DE (1) DE3481973D1 (it)
IT (1) IT1178809B (it)
NO (1) NO843587L (it)
WO (1) WO1984002649A1 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0190797A3 (en) * 1985-02-08 1987-05-20 John Kenneth Voit Method for killing viruses and composition therefor
AU2493792A (en) * 1991-07-10 1993-02-11 Jury Semenovich Krivoshein Pharmaceutical preparation
RU2161961C1 (ru) * 2000-03-17 2001-01-20 Кривошеин Юрий Семенович Лекарственный препарат
EP2359690A1 (fr) 2010-02-23 2011-08-24 East Coast Pharmaceutical Research LLC Multiplication de l'efficacité des agents anti-infectieux par une composition comprenant conjointement un agent dispersant et un agent activateur métallique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2295504A (en) * 1938-08-01 1942-09-08 Wm S Merrell Co Cetyl quaternary ammonium compound
US2666009A (en) * 1950-09-05 1954-01-12 California Research Corp Quaternary ammonium germicide compositions
US4262007A (en) * 1979-04-13 1981-04-14 George F. Sherrill Method for the treatment of viral skin diseases

Also Published As

Publication number Publication date
JPS60500447A (ja) 1985-04-04
DE3481973D1 (de) 1990-05-23
WO1984002649A1 (en) 1984-07-19
IT8467014A0 (it) 1984-01-09
IT1178809B (it) 1987-09-16
AU2439884A (en) 1984-08-02
JPH07106980B2 (ja) 1995-11-15
AU569279B2 (en) 1988-01-28
CA1228551A (en) 1987-10-27
IT8467014A1 (it) 1985-07-09
EP0131050A4 (en) 1985-09-09
EP0131050A1 (en) 1985-01-16
EP0131050B1 (en) 1990-04-18

Similar Documents

Publication Publication Date Title
US4757088A (en) Antiviral pharmaceutical preparations and methods for their use
Chou et al. Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications
Romanowski et al. Efficacy of topical cidofovir on multiple adenoviral serotypes in the New Zealand rabbit ocular model
Schuster et al. Phenothiazine compounds inhibit in vitro growth of pathogenic free-living amoebae
US4760079A (en) Treatment of diseases caused by herpes viruses
US4935448A (en) Treatment of diseases caused by herpes viruses
NO843587L (no) Behandling av sykdommer foraarsaket av herpesvira
KAUFMAN Chemotherapy of herpes keratitis
Shiota et al. Efficacy of acycloguanosine against herpetic ulcers in rabbit cornea.
Hyndiuk et al. Newer compounds in therapy of herpes simplex keratitis
Tseng et al. Progressive outer retinal necrosis associated with occlusive vasculitis in acquired immunodeficiency syndrome
US4914131A (en) Antiviral pharmaceutical preparations and methods for their use
Pavan-Langston et al. Ganglionic herpes simplex and systemic acyclovir
US5158980A (en) Treatment of diseases caused by herpes viruses
EP1858531A1 (en) Use of copper silicate for the control of herpes infections
WO1996025163A1 (en) Treatment of herpes simplex viruses
Kaufman et al. Oral antiviral drugs in experimental herpes simplex keratitis
Pavan-Langston et al. 5'-Amino-5'-deoxythymidine: Topical therapeutic efficacy in ocular herpes and systemic teratogenic and toxicity studies
Kawali et al. Primary treatment failure in acute retinal necrosis–A comprehensive review
Sidwell et al. Viral keratitis-inhibitory effect of 9-β-D-arabinofuranosylhypoxanthine 5′-monophosphate
Boisjoly et al. Herpes simplex acyclovir-resistant mutant in experimental keratouveitis
Schulman et al. Intraocular acyclovir levels after subconjunctival and topical administration.
AU2010212386A1 (en) Topical antiviral therapeutic and prophylactic treatment of adenoviruses and their associated diseases
Garza, Jr et al. Effect of a beta-adrenergic antagonist, propranolol, on induced HSV-1 ocular recurrence in latently infected rabbits
Kaufman Successful therapy of viral keratitis